Status:
COMPLETED
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Refractory Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will enroll patients with epilepsy who are being evaluated for epilepsy surgery and have intracranial EEG electrodes. In this study, the aim is to record brain signals from areas important ...
Detailed Description
One to two study tasks will be performed by each participant to help us understand how the brain processes emotion and how stimulation effects emotional processing. These study tasks will last up to ...
Eligibility Criteria
Inclusion
- Age of 18 years or older
- FSIQ 75 and above or any equivalent test of generalized intelligence as determined by the PI to adequately predict engagement in the task
- Able to give independent consent for participation in the study
Exclusion
- Additional neurological disorders (such as dementia, stroke, brain tumor, etc.)
- Any psychiatric condition that would limit their ability to provide consent and/or perform study tasks within normal limits. This would be based on presurgical psychiatric assessment.
- Anything else, that in the opinion of the principal investigator, might preclude them from participating in the study
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 16 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05292183
Start Date
March 31 2022
End Date
February 16 2024
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03776